Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials

被引：35

作者：

Franklin, Jessica M. ^{[1
]}

Glynn, Robert J. ^{[1
]}

Suissa, Samy ^{[2
,3
,4
]}

Schneeweiss, Sebastian ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[2] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada

[3] McGill Univ, Dept Biostat, Montreal, PQ, Canada

[4] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷 / 04期

关键词：

D O I：

10.1002/cpt.1793

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Actionable real-world evidence (RWE) requires accurate estimation of causal treatment effects. Calibration of RWE against randomized controlled trials (RCTs) is sometimes done to demonstrate that RWE can support the same causal conclusion as RCTs. Disagreements can occur when studies in each pair asked different questions in different populations or due to the presence of residual bias. Distinguishing among reasons for differences will impact the level of confidence in RWE.

引用

页码：735 / 737

页数：3

共 50 条

[1] Real-world evidence vs. randomized control trials
Deleuran, M.
Vestergaard, C.
BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) : 275 - 276
[2] Calibrating real-world evidence studies against randomized trials: Treatment effectiveness of infliximab in inflammatory bowel disease
Kirchgesner, Julien
Desai, Rishi J.
Schneeweiss, Maria C.
Beaugerie, Laurent
Kim, Seoyoung C.
Schneeweiss, Sebastian
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 41 - 42
[3] Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease
Kirchgesner, Julien
Desai, Rishi J.
Beaugerie, Laurent
Kim, Seoyoung C.
Schneeweiss, Sebastian
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 179 - 186
[4] Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Re, Rafael
Janiaud, Perrine
Ioannidis, John P. A.
BMC MEDICINE, 2018, 16
[5] Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials
Wang, Shirley, V
Schneeweiss, Sebastian
Gagne, Joshua J.
Evers, Thomas
Gerlinger, Christoph
Desai, Rishi
Najafzadeh, Mehdi
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (05) : 1156 - 1163
[6] Unit information prior for incorporating real-world evidence into randomized controlled trials
Zhang, Hengtao
Yin, Guosheng
STATISTICAL METHODS IN MEDICAL RESEARCH, 2023, 32 (02) : 229 - 241
[7] Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Rafael Dal-Ré
Perrine Janiaud
John P. A. Ioannidis
BMC Medicine, 16
[8] Randomized controlled trials and real-world data: differences and similarities to untangle literature data
Monti, Sara
Grosso, Vittorio
Todoerti, Monica
Caporali, Roberto
RHEUMATOLOGY, 2018, 57 : 54 - 58
[9] The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology
Merola, David
Campbell, Ulka
Gautam, Nileesa
Rubens, Alexa
Schneeweiss, Sebastian
Wang, Shirley V. V.
Carrigan, Gillis
Chia, Victoria
Ovbiosa, Osayi E. E.
Pinheiro, Simone
Bruno, Amanda
Jiao, Xiaolong
Stewart, Mark
Hendricks-Sturrup, Rachele
Rodriguez-Watson, Carla
Khosla, Sajan
Zhang, Yiduo
Rimawi, Mothaffar
Huang, Jenny
Taylor, Aliki
Becnel, Lauren
McRoy, Lynn
Eckert, Joy
Taylor, Benjamin
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (06) : 1217 - 1222
[10] "Real-World" Evidence, Target Trial Emulation, and Randomized Clinical Trials-Which Data Should Clinicians Rely on When Choosing Antibiotics?
Paterson, David L.
Sulaiman, Helmi bin
JAMA NETWORK OPEN, 2024, 7 (01)

← 1 2 3 4 5 →